Therapeutic approaches in young women with advanced or metastatic breast cancer

García‐Palomo, Andrés

doi:10.1007/s10549-010-1071-0

Cited by 2 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is a higher proportion of TNBC and HER2+ disease in young women with metastatic breast cancer [ 344 , 345 ]. The first-line treatment is chemotherapy, with or without targeted therapy.…”

Section: Treatmentmentioning

confidence: 99%

What Is Known about Breast Cancer in Young Women?

Zhu

Charkhchi

Adekunte

et al. 2023

Cancers

View full text Add to dashboard Cite

Breast cancer (BC) is the second leading cause of cancer-related death in women under the age of 40 years worldwide. In addition, the incidence of breast cancer in young women (BCYW) has been rising. Young women are not the focus of screening programs and BC in younger women tends to be diagnosed in more advanced stages. Such patients have worse clinical outcomes and treatment complications compared to older patients. BCYW has been associated with distinct tumour biology that confers a worse prognosis, including poor tumour differentiation, increased Ki-67 expression, and more hormone-receptor negative tumours compared to women >50 years of age. Pathogenic variants in cancer predisposition genes such as BRCA1/2 are more common in early-onset BC compared to late-onset BC. Despite all these differences, BCYW remains poorly understood with a gap in research regarding the risk factors, diagnosis, prognosis, and treatment. Age-specific clinical characteristics or outcomes data for young women are lacking, and most of the standard treatments used in this subpopulation currently are derived from older patients. More age-specific clinical data and treatment options are required. In this review, we discuss the epidemiology, clinicopathologic characteristics, outcomes, treatments, and special considerations of breast cancer in young women. We also underline future directions and highlight areas that require more attention in future studies.

show abstract

Section: Treatmentmentioning

confidence: 99%